Supporting safe and effective therapies
Normec supports biotech companies, biopharmaceutical organisations, research institutes and CROs with high-quality bioanalytical services for biologics, small molecules, and cell and gene therapies. By combining speed, quality and regulatory compliance, we help ensure that development programmes progress efficiently and under control.
With more than 20 years of experience, we support every stage of drug development, from discovery and preclinical research through to clinical development.
PK studies and bioanalytical assays
Bioanalytical CRO services rely on accuracy, reproducibility and reliable data. That is why we combine advanced analytical technologies with experienced specialists who understand the importance of quality and fast turnaround times throughout the drug development process.
Our expertise includes:
- Pharmacokinetic (PK) and toxicokinetic studies
- Bioanalytical assays for biologics and small molecules
- Immunogenicity testing
- Cytokine and biomarker analysis
- Cell-based assays for advanced therapies
We use advanced technologies such as LC-MS/MS, ELISA, flow cytometry and PCR to deliver high-quality, regulatory-compliant results.
From discovery to clinical development
Reliable bioanalysis enables organisations to make faster, better-informed decisions throughout research and development. We support both preclinical and clinical studies by generating high-quality data for safety, efficacy and pharmacokinetic evaluations.
Our expertise helps you to:
- Perform PK studies efficiently and accurately
- Develop and validate reliable bioanalytical assays
- Strengthen support for preclinical and clinical programmes
- Ensure compliance with GLP and GCP requirements
- Accelerate development programmes while maintaining control and quality
Expertise in bioanalytical CRO services
Our specialists have extensive experience with biologics, small molecules and advanced therapies, including cell and gene therapies. By working closely with our clients, we provide flexible support, rapid turnaround times and reliable results that contribute to successful development programm
The future of drug development
The development of innovative therapies depends on reliable data, advanced analytical technologies and effective collaboration. That is why we help organisations future-proof their bioanalytical processes while accelerating drug development.
Together, we contribute to innovative solutions that shape the future of healthcare and life sciences.
Would you like to know more about bioanalytical CRO services?
Frequently Asked Questions
-
Bioanalytical CRO services support organisations with bioanalysis during preclinical and clinical studies as part of the drug development process.
-
Pharmacokinetic (PK) studies investigate how a drug is absorbed, distributed, metabolised and eliminated by the body.
-
Bioanalytical assays are analytical tests used to measure drugs, biomarkers or biological responses during research and development.
-
We provide bioanalytical services for biologics, small molecules, cell therapies and gene therapies.
-
We use a range of advanced analytical techniques, including LC-MS/MS, ELISA, flow cytometry and PCR.
-
GLP and GCP guidelines help ensure quality, data integrity and regulatory compliance throughout research and development programmes.
-
Yes. We support organisations throughout every stage of drug development, from discovery to clinical development.